QXMédical Launches ResQ Occlusion Balloon Catheter
April 12, 2017—QXMédical, LLC recently announced the launch of the ResQ occlusion balloon catheter, which is designed to provide optimal user control to occlude large vessels and manage bleeding during surgical and trauma procedures, including resuscitative endovascular balloon occlusion of the aorta (REBOA). The device is now available in the United States.
According to the company, the ResQ device features a low-profile, 8-F shaft designed for stability, minimal migration, and rapid balloon inflation/deflation. The balloon compliance characteristics have been engineered to allow the user optimal tactile feedback during balloon inflation and vessel occlusion.
The ResQ's balloon has a diameter range of 10 to 38 mm allowing for a large range of applications. The catheter is compatible with 11-F introducer sheaths and 0.035-inch diameter guidewires. The catheter's length is 67 cm, making it easy to manage and compatible with short guidewires.
As noted by QXMédical, REBOA is an endovascular procedure requiring placement of an occlusion balloon in the aorta to control bleeding resulting from traumatic injury. The balloon catheter is typically inserted through an introducer sheath placed in the femoral artery and then advanced to the appropriate location in the aorta, and inflated to occlude the vessel and control bleeding. Several REBOA training courses are now available to trauma surgeons and personnel, including the BEST (Basic Endovascular Skills for Trauma) Course sponsored by the American College of Surgeons, noted the company.
In other company news, QXMédical announced the company's partnership with EVARplanning, a free endovascular stent graft configuration and rendering system. EVARplanning uses an original algorithm based on a database of commonly used aortic endoprostheses and helps vascular surgeons find the best endograft configuration based on the patient's sizes.